Arndt Vogel/aasld.org
Aug 8, 2025, 05:01
Arndt Vogel: ESMO-MCBS 2.0 Scorecards for Hepatocellular Carcinoma
Arndt Vogel, Head of the Visceral Oncology Center, Head of the Center for Personalized Medicine, MHH, and Senior Consultant of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, shared a post on X:
“Hot off the press: ESMO-MCBS 2.0 Scorecards now available. Do you agree with the proposed benefit? Check them out for Hepatocellular Carcinoma.”
More posts featuring Arndt Vogel on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 05:01
Aug 7, 2025, 21:48
Aug 7, 2025, 21:02
Aug 7, 2025, 20:53
Aug 7, 2025, 19:57
Aug 7, 2025, 19:49